PT  - JOURNAL ARTICLE
AU  - Alyami, Hamad S.
AU  - Naser, Abdallah Y
AU  - Dahmash, Eman Zmaily
AU  - Alyami, Mohammed H.
AU  - Al Meanazel, Osama T.
AU  - Al-Meanazel, Ayat T.
AU  - Al Meanazel, Osaid T.
TI  - “Depression and anxiety during 2019 coronavirus disease pandemic in Saudi Arabia: a cross-sectional study”
AID  - 10.1101/2020.05.09.20096677
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.09.20096677
4099  - http://medrxiv.org/content/early/2020/05/15/2020.05.09.20096677.short
4100  - http://medrxiv.org/content/early/2020/05/15/2020.05.09.20096677.full
AB  - Background COVID-19 outbreak in 2020 was associated with a high rate of depression and anxiety among individuals in the affected countries. The aim of this study is to explore the influence of the COVID-19 epidemic on the psychological distress of residents of the Kingdom of Saudi Arabia.Methods A cross-sectional study using an online survey was conducted in Saudi Arabia between 27th of March and 27th of April 2020. The Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) were used to assess depression and anxiety. Logistic regression analysis was used to identify predictors of depression and anxiety.Results The prevalence of depression and anxiety among the entire study participants was 9.4% and 7.3%, respectively. Non-Saudi residents, aged 50 years and above, divorced, retired, university students, and those with income (2000 - 10,000 RS) were at higher risk of developing depression. Saudi individuals, married, unemployed, and those with high income (> 10,000 RS) were at higher risk of developing anxiety.Conclusions There is a wide range of the Saudi residents who are at higher risk of mental illness during COVID-19 pandemic. Policymakers and mental healthcare providers are advised to provide continuous monitoring of the psychological consequences during this pandemic, and provide mental support.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author upon reasonable request.